1997
DOI: 10.1016/s0016-5085(97)70118-5
|View full text |Cite
|
Sign up to set email alerts
|

Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
55
0
7

Year Published

1998
1998
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 138 publications
(64 citation statements)
references
References 2 publications
2
55
0
7
Order By: Relevance
“…The utility of NSRS state was derived from two studies that reported QOL weights for patients with gastroesophageal reflux disease and achalasia (0.72 [0.64 -0.75]). 15,16 According to the time required for recovery, a disutility was assigned to each of the various short-term postoperative health states. The utilities and the total QOL weight for each year a patient undergoes an operation was calculated using the formula:…”
Section: Appendix Bmentioning
confidence: 99%
“…The utility of NSRS state was derived from two studies that reported QOL weights for patients with gastroesophageal reflux disease and achalasia (0.72 [0.64 -0.75]). 15,16 According to the time required for recovery, a disutility was assigned to each of the various short-term postoperative health states. The utilities and the total QOL weight for each year a patient undergoes an operation was calculated using the formula:…”
Section: Appendix Bmentioning
confidence: 99%
“…The scientific attempts to elucidate the problem have hitherto been limited to either retrospective studies or studies in which computer-based modeling has been used [58][59][60][61]. Although some information of clinical value can be obtained from such studies they suffer from inherent and well-known methodological weaknesses.…”
Section: Cost-effectiveness Of Antireflux Surgerymentioning
confidence: 99%
“…The estimated cost per year from each strategy was: $1,230 for H 2 RA, $1,411 for PPI, $1,598 for UGI series, and $2,159 for endoscopy. 77 From these adult studies, it is reasonable to extrapolate evidence supporting empiric treatment of pediatric patients with GERD without alarm signs, and a rational choice would be to use PPIs for more severe symptoms and use H 2 RAs for mild to moderate symptoms. With moderate to severe GERD not responsive to empiric PPI therapy, the dose of PPIs may be increased, but referral to the gastroenterologist is warranted to eliminate causes other than GERD and evaluate the need for possible surgical treatment.…”
Section: Treatment Approachmentioning
confidence: 99%